For research use only. Not for therapeutic Use.
m-PEG11-acid(Cat No.:I016796) is a linker molecule that contains 11 polyethylene glycol (PEG) units and is used to synthesize antibody-drug conjugates (ADCs) and proteolysis-targeting chimeras (PROTACs). As an ADC linker, it is non-cleavable and is used to attach drugs to the targeting antibody. As a PROTAC linker, it belongs to the PEG class and is used to connect the ligand for the target protein with a ligand for an E3 ubiquitin ligase, leading to targeted protein degradation. The PEG units in m-PEG11-acid provide water solubility and improve the pharmacokinetic properties of the resulting ADCs and PROTACs.
Catalog Number | I016796 |
CAS Number | 2280998-74-3 |
Molecular Formula | C₂₄H₄₈O₁₃ |
Purity | ≥95% |
Target | PROTAC |
IUPAC Name | 3-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]propanoic acid |
InChI | InChI=1S/C24H48O13/c1-27-4-5-29-8-9-31-12-13-33-16-17-35-20-21-37-23-22-36-19-18-34-15-14-32-11-10-30-7-6-28-3-2-24(25)26/h2-23H2,1H3,(H,25,26) |
InChIKey | XTRVAOVFCQZNBJ-UHFFFAOYSA-N |
SMILES | COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)O |
Reference | [1]. Wilfried Braje et al. Macrocyclic mcl-1 inhibitors and methods of use. WO2019035927A1.<br>[2]. An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562. |